
For one breast cancer survivor, the effects of treatment on sexual health took years to identify. Menopause had changed how her body responded to sex, but no one on her care team discussed what to expect or how to address it. Only later, after training as a menopause specialist, did she recognize that changes in clitoral and vulvar tissue were behind the diminished sensation, discomfort and difficulty becoming aroused she had come to accept.
Her experience points to a gap in cancer care: patients may receive extensive treatment for the disease while sexual side effects go unmentioned. Her account also shows why it can take self-advocacy—and a clinician who understands menopause—to find options that improve symptoms.
A diagnosis at 28 changed her health and her work
In 2001, she was a second-year obstetrics and gynecology resident, newly married to her college sweetheart and 28 years old. She felt a breast lump but initially dismissed it, assuming she was too young to have breast cancer. Even fellow physicians shared that assumption. A few months later, her mother was diagnosed with late-stage ovarian cancer and died soon afterward. At her mother's funeral, she decided to have the lump checked.
The diagnosis was stage 2A estrogen receptor-positive breast cancer. Her treatment included a bilateral mastectomy and six months of chemotherapy. She entered menopause three times: chemotherapy brought it on, it was later medically induced, and years afterward she chose to have her ovaries removed because of her mother's ovarian cancer history.
Her medical training hadn't prepared her for the sexual and physical changes that can accompany premature menopause. Nor, she says, did her care team explain the possible effects. She doesn't know whether they lacked the information or simply didn't consider it relevant to discuss. Either way, she was young, newly married and unaware of what symptoms to watch for.
Gradual changes became her new normal
Sex began to feel different. Her sexual response diminished, arousal took longer, and vaginal dryness made sex more painful. She later learned that clitoral atrophy—a change in which the clitoris shrinks or responds less to arousal—could explain some of what she was experiencing. She also recognized vulvar atrophy.
At the time, she didn't have those terms for her symptoms. She had adjusted to them and assumed sex changed with age. Sometimes she had sex to maintain the relationship, even when the experience wasn't pleasurable. The fact that these changes developed in the context of menopause, rather than arriving as a single obvious event, helped them go unnoticed for years.
She eventually encountered new discussions of menopause treatment at professional conferences while working as a menopause specialist. Those conversations led her to reconsider her own symptoms and pursue treatment. Looking back, she describes having grown passive about her sexual health; the conferences helped her see that the changes could be addressed.
Her story is a reminder that a change in sexual function can be a symptom worth bringing to a clinician, even if it has become familiar or seems like an inevitable part of getting older. The link to menopause may not be apparent to someone who wasn't told to expect it.
Finding a treatment approach that helped
She began with localized vaginal estrogen, which is applied in the vagina and which she says was considered safe for her type of cancer. She then added low-dose testosterone to address low libido. She points to estrogen and testosterone receptors in vulvar, vaginal and clitoral tissue as part of the reason hormones can matter for these symptoms.
The combination made a marked difference for her. As sexual sensation improved, she realized how far it had shifted: the experience of sex felt familiar in a way it hadn't for years. Her description is simple: she hadn't understood the extent of what had changed until she experienced improvement.
Her account describes her own care and should not be read as a treatment plan for every survivor. The therapies she used, and whether they are appropriate, depend on the individual and their medical history. She argues, however, that a history of breast cancer shouldn't mean patients are left without a conversation about sexual symptoms or possible care.
Symptoms vary, and can affect pleasure in different ways
In her current menopause practice, she sees patients whose symptoms are more severe than hers were. Some can't reach orgasm. Others develop scarring or adhesions around the clitoral hood, which can interfere with pleasure. The range matters: there isn't one experience of clitoral atrophy, and patients may not describe the same symptoms or degree of impact.
She also warns that these changes can progress over time without treatment. That makes it useful to raise new or persistent symptoms rather than waiting until they become difficult to ignore. The clinician's experience has shaped her work with menopause patients and her efforts to help cancer survivors understand that suffering through sexual changes isn't their only option.
In her view, conversations about possible sexual side effects should be part of informed consent when patients begin cancer medication. People shouldn't have to discover these effects years later or figure out how to seek help on their own. She says patients starting cancer treatment can ask their oncologist directly: “I'm concerned about sexual side effects. What can you do to prevent them from happening?”
She notes that patients may be advised to try non-hormonal, over-the-counter moisturizers and lubricants. Those can help with symptoms, she says, but won't address underlying changes involving collagen and blood flow. She also points to published studies on low-dose hormones for breast cancer survivors, including some receiving active treatment. A discussion with a patient's own care team is still central to deciding what options fit their situation.
Two decades later, advocacy is part of her care
Twenty-four years after her diagnosis, she reports being in good health with no evidence of disease. Her menopause symptoms are controlled, and she says her sexual health is good. Reaching that point took time and repeated effort to get the care she needed.
Now, her experience informs how she talks with patients. A cancer diagnosis and its treatment can affect sexual health long after the initial care decisions, and those effects may go unnamed unless someone raises them. Her concrete advice is to bring concerns to the oncology team early and keep asking about symptoms that persist. For clinicians, her story makes a case for including sexual health in treatment conversations, so patients have a clearer path to care.
- As told to Korin Miller
Korin Miller is a writer specializing in general wellness, health, and lifestyle trends. Her work has appeared in Women's Health, Self, Health, Forbes, and more.
===